Allied Academies was founded by Jim and JoAnn Carland and the headquarters is located in North Carolina in United States of America. It conducts several academic conferences each year in different locations with internet participation possibilities for those who are physically unable to attend the conferences. Conference registrants are eligible for the Accelerated Journal Review. To provide you with maximum outlets for your research, Allied Business Academies holds joint meetings of all its member academies. In 1994 they launched the Journal of the International Academy of Case Studies, which has become a leader in publishing classroom teaching cases in business.
Cancer is a group of diseases that is caused due to abnormal cell growth and their potential to invade or spread to other parts of the body. Oncology is a branch of medicine that deals with the prevention, diagnosis and treatment of cancer. Benign tumors do not spread to other parts of the body. There are more than 100 types of cancer including breast cancer, skin cancer, lung cancer, colon cancer, prostate cancer, and lymphoma. Symptoms vary depending on the types of cancer. Cancer treatment may include chemotherapy, radiation, and/or surgery.
Preventive Oncology is defined as active measures to decrease the risk of cancer. The vast majority of cancer cases are due to environmental risk factors, and many, but not all, of these environmental factors are controllable lifestyle choices. Greater than 30% of cancer deaths could be prevented by avoiding risk factors including: tobacco, overweight / obesity, an insufficient diet, physical inactivity, alcohol, sexually transmitted infections, and air pollution. Not all environmental causes are controllable, such as naturally occurring background radiation, and other cases of cancer are caused through hereditary genetic disorders, and thus it is not possible to prevent all cases of cancer
Preventive Oncology 2017 is the great platform for everybody to put forth their ideas of Cancer research and ways to prevent the cancer risk.
Allied Academies invites all the participants from all over the world to attend “World Congress on Preventive Oncology” which will be held in Las Vegas, Nevada, USA during October 05-06, 2017 which includes prompt Keynote Presentations, Special Sessions, Workshops, Symposiums, Oral talks, Poster Presentations and Exhibitions. The main theme of the conference is “Advanced Therapeutic and Modern Oncological Technologies”. So, Let us all join together and fight against Cancer.
Why Las Vegas?
Las Vegas officially the City of Las Vegas and often known simply as Vegas, is the 28th-most populated city in the United States, the most populated city in the state of Nevada, and the county seat of Clark County. Las Vegas is an internationally renowned major resort city known primarily for its gambling, shopping, fine dining, entertainment, and nightlife. It is the leading financial, commercial, and cultural center for Nevada.
Nevadans are more likely to contract and die of cancer, according to a study. The report, released by the University of Nevada, Las Vegas and Nevada State Health Division last week, notes cancer rates in the region comprising Nevada, California, Utah and Arizona historically have been lower than the national average. But Nevada showed significantly higher rates of all cancers than those other states between 2006 and 2008, according to the report. Nevada had a cancer incident rate of 457 per 100,000 people, compared with 442 for California, 397 for Utah and 394 for Arizona. Thus a conference related to oncology, especially preventive oncology is essential in such an area to create awareness among the people about the risks and management of different types of cancer. And Las Vegas is a central place to focus such a wide topic to create awareness as well as a good tourist place to have visited by most of the people.
Allied Academies welcomes you all with a great pleasure and honor to extend a warm invitation to attend the “World Congress on Preventive Oncology” which will be held in Las Vegas, Nevada, USA during October 05-06, 2017.
The Main theme of the conference is “Advanced Therapeutic and Modern Oncological Technologies ".
Preventive Oncology 2017 will be a great platform for research scientists and young researchers to share their current findings in the field of applied sciences.
Preventive Oncology 2017- Market Analysis:
Preventive Oncology is utilized to treat malignancy through different strategies. Few treatment techniques like surgery, chemotherapy, radiation treatment, hormonal treatment, and focused on treatment (counting immunotherapy) can be utilized to treat growth. The area of treatment of growth relies on upon the kind of tumor.
Importance & Scope
Preventive Oncology 2017 will be the best stage for every one of the oncologists, hematologists, Pathologists, Radiologists, Academics, explore researchers, understudies who are working in this field to trade their insight identified with Cancer and treatment. This worldwide occasion is a push to comprehend the fundamental organic methodology which is revised to build adequacy, exactness, survivability, and nature of life. Experts will clarify how another era of treatment choices gives patients new trust in the battle against disease. Geographically, the worldwide disease treatment market is ordered into areas to be specific, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa .North America takes the biggest share of worldwide malignancy treatment advertise took after by Europe.
Cancer is the second leading cause of death worldwide and in all regions of the world except sub-Saharan Africa. Historically, the USA had a much lower incidence of cancer than other countries; however, over the last 40 years, it has undergone a period of dramatic economic, social, and demographic change, resulting in increased life expectancy and prosperity.
Cancer, which is now the third leading cause of death in the USA (after cardiovascular disease and injury) causing 30% of all deaths in 2012 and 46% of all deaths in the France during the same year. The incidence of all cancers is projected to double by 2020, primarily due to ageing and also possibly due to increased exposure to risk factors for cancer. Breast cancer is the most common cancer among Paris females (and the most prevalent cancer in both sexes combined), lung cancer is the most common cancer amongst Paris males but is extremely rare in females, which reflects the prevalence of smoking (33.0% vs. 0.5%, respectively), and colorectal cancer is the second most common cancer.
Approximately 12.7 million cancer cases and 7.6 million cancer deaths are estimated to have occurred in 2008; of these, 56% of the cases and 64% of the deaths occurred in the economically developing world.
01. Preventive Oncology:
Preventive oncology is any measure that is taken to prevent development
or progression of malignant process. Around one third of cancer deaths are due
to the five leading behavioral and dietary risks: high body mass index, low
fruit and vegetable intake, lack of physical activity, tobacco use, alcohol
use, and one half of all cancer cases either arise from modifiable risk factors
or can be detected as precursor lesions before the development of disease with
Prevention of cancer can take place on several different levels: primary prevention addresses the cause of cancer so disease does not occur, secondary prevention identifies disease before the onset of symptoms and keeps it from becoming more extensive, and tertiary prevention reduces complications and progression of disease once it has become clinically apparent.
- Gene therapy may help prevent cancer metastasis
- Blood sample new way of detecting cancer
- Breakthrough: Using skin cells to kill cancer
- T-Cell Therapy gives hope for advanced lymphoma
02. Molecular Oncology:
Molecular Oncology refers to the investigation of the chemistry of cancer and tumors at the molecular scale. The examination of the science of malignancy and tumors at the sub-atomic scale. Additionally the advancement and use of molecularly focused on treatments. In atomic oncology the distinguish qualities are included in the improvement of disease.
- Molecular Diagnosis
- Pre malignant lesions
- Cancer genetics
- Integrating tumor microenvironment
- Cancer immunotherapy
03. Cancer Cell Metabolism:
Tumor cells metabolize glucose, lactate, pyruvate, hydroxybutyrate, acetate, glutamine and fatty acids at much higher rates than their non-tumor equivalents; however, the metabolic ecology of tumors is composite because they contain multiple metabolic compartments, which are linked by the transfer of these catabolites. This metabolic changeability and flexibility enables tumor cells to generate ATP as an energy source, while maintaining the reduction–oxidation (redox) balance and committing resources to biosynthesis processes that are essential for cell survival, growth and proliferation.
- Metabolic immuno –oncology
- Molecular-Genetic Imaging
- Preclinical and clinical studies of metabolism-related cancer therapies
04. Oral and Oropharyngeal Cancer:
Oral cavity cancers the tumor is growing into an area called the masticator space and Oropharyngeal cancers the tumor is growing into a muscle called the lateral pterygoid muscle. And the tumor is growing into the nasopharynx (the area of the throat that is behind the nose).
- Indirect pharyngoscopy and laryngoscopy diagnostic procedures
- Direct (flexible) pharyngoscopy and laryngoscopy
05. Anti-Cancer Drugs:
Anticancer drugs are used to control the growth of cancerous cells. Cancer is commonly defined as the uncontrolled growth of cells, with loss of differentiation and commonly, with metastasis, spread of the cancer to other tissues and organs. Anticancer medications are utilized when the tumor has spread, or may spread, to all regions of the body.
- Drug Discovery
- Adverse effects
- Nanotechnology in cancer drugs
06. Cancer Immuno-prevention:
Cancer immune prevention is the prevention of cancer onset with immunological means such as vaccines, Immuno-stimulators or antibodies. Most tumor-associated antigens (TAA) are self-molecules that are abnormally expressed in cancer cells and become targets of antitumor immune responses. Antibodies and T cells specific for some TAAs have been found in healthy individuals and are associated with lowered lifetime risk for developing cancer. Lower risk for cancer has also been associated with a history of febrile viral diseases. A CIP study identified new antibodies against tumor cell proteins that were elicited by influenza infection. Cancer vaccines based on human tumor-associated antigens (TAA) have been tested in patients with advanced or recurrent cancer, in combination with or following standard therapy.
- Immuno Prevention of Tumors Caused by Viruses
- Immuno Prevention of non-infectious tumor
- Cancer Immune Editing
- Immune Response
07. Cancer Epidemiology:
Cancer epidemiology is the study of the distribution and determinants of the likelihood of cancer development. Cancer epidemiology can be used to identify events that increase or decrease cancer occurrence in specific people cancer epidemiology uses epidemiological methods to find the cause of cancer and to identify and develop improved treatments. Normally Squamous cell carcinoma of the lung is a central rather than a peripheral form of lung cancer. Rates of squamous cell carcinoma in the lung periphery are typically sited in the 15-30% range. Given the differences in cell biology and carcinogenesis of central versus peripheral SCC, a potential epidemiologic shift might suggest a change in tumor biology.
- Hepatocellular carcinoma
- Squamous cell carcinoma epidemiology
- Prostate cancer
08. Gynecologic Oncology:
A Gynecologic oncology is study of which specializes in the diagnosis and treatment of women with cancer of the reproductive organs Including ovarian cancer, uterine cancer, vaginal cancer, cervical cancer, and vulvar cancer. The primary treatment for ovarian cancer, followed in most patients by systemic chemotherapy. By the Aggressive exploitation of operative laparoscopy, even only for selected patients, into the surgical practice of a gynecologic oncology service demonstrates significant improvements in LOS (laparoscopy on length of stay) without adversely affecting surgical complication rates based on different types of cancers.
- Cervical cancer
- Endometrial/uterine cancer
- Gestational trophoblastic disease
- Ovarian cancer- including fallopian tube, peritoneal, germ cell, and stromal cell
- Vaginal cancer
- Vulvar cancer
09. Hematologic Oncology:
A hematologic-oncology is the study
that involves in the diagnosis, treatment and/or prevention of blood diseases
and cancers such as iron-deficiency anemia, hemophilia, sickle-cell disease,
leukemia and lymphoma. This physician is trained in hematology — the study of
blood — and oncology — the study of cancer. Hematologist-oncologists do not
usually treat operable cancers such as prostate cancer, but specialize in treating
blood cancers, such as Hodgkins and non-Hodgkins lymphomas, leukemias and
multiple myelomas. A hematologist-oncologist may also specialize in the
management of solid tumors.
Hematologists also conduct studies in oncology and work with oncologists, people who may specialize only in that field instead of both-the medical treatment of cancer. There are various disorders that people are affected by hematology. A few of these different types of blood conditions that are looked at include anemia, hemophilia, general blood clots, bleeding disorders, etc. As for related blood cancers such as leukemia, myeloma, and lymphoma, these are more serious cases that need to be diagnosed
- Myelodysplastic syndromes
- Multiple Myeloma
10. Stem Cells Therapy:
Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. In a typical stem cell transplant for cancer very high doses of chemo are used, sometimes along with radiation therapy, to try to kill all the cancer cells. This treatment also kills the stem cells in the bone marrow. Soon after treatment, stem cells are given to replace those that were destroyed. These stem cells are given into a vein, much like a blood transfusion. Over time they settle in the bone marrow and begin to grow and make healthy blood cells. This process is called engraftment.
- Autologous stem cell transplants
- Tandem transplants
- Allogeneic stem cell transplants
- Syngeneic stem cell transplants
- Half-matched transplants
11. Medical & Surgical Cancer:
Surgery is the removal of the tumor and surrounding tissue during an operation. A doctor who specializes in treating cancer using surgery is called a surgical oncologist. Surgery is the oldest type of cancer therapy and remains an effective treatment for many types of cancer today. For most types of cancer, a biopsy is the only way to make a definitive diagnosis. During a surgical biopsy, the surgeon makes a cut called an incision in the skin. Then, he or she removes some or all of the suspicious tissue. Tumor removal, also called curative or primary surgery. Surgery is most commonly used to remove the tumor and some of the surrounding healthy tissue. The tissue surrounding the tumor is called the margin.
- Reconstructive surgery
- Lung cancer surgery
- Photodynamic Therapy
12. Cancer Cell Biology:
The cell is the fundamental unit of life. It is the smallest structure of the body capable of performing all of the processes that define life. Each of the organs in the body, such as the lung, breast, colon, and brain, consists of specialized cells that carry out the organ's functions such as the transportation of oxygen, digestion of nutrients, excretion of waste materials, locomotion, reproduction, thinking, etc. here are two general sorts of quality transformations. One write, prevailing change, is brought about by a variation from the norm in one quality in a couple. The second broad kind of transformation, latent change, is described by both qualities in the pair being harmed.
- Cancer biology
- Cell cycle
- Risk factors
- Cancer genetics
- Nanotechnology in Cancer
13. Radiation Oncology:
Radiation therapy occurs in the presence of biochemical recurrence after prostatectomy to assess whether this results in shifts of Histo-pathological prognostic factors such as the Gleason Score by using ionizing radiation (such as mega-voltage X-rays or radionuclides) in the treatment of cancer. The field of radiation oncology covers the integration of radiation therapy into multimodal treatment approaches. Radiation Oncology provides an open access forum for researchers and clinicians involved in the management and treatment of cancer patients, bringing together the latest research and advances in the field. Advances in treatment technology, as well as improved understanding of the underlying biological resistance mechanisms, will further strengthen the role of radiation oncology.
- Radiation therapy
- Stereotactic body radiation therapy (SBRT)
- Intensity Modulated Radiotherapy (IMRT)
- Intravascular Brachytherapy
- Prostate Seed Implant
14. Cellular Reprogramming:
It is provides for bits of learning on the etiology, change, and potential treatment of various ailments through reproducing cell instruments. Cell reconstructing is the way toward guiding full grown cells to a primitive condition of quality expression. The etiology and pathogenesis of SLE have not been completely seen. Innate, biological and viral maladies and diverse components might be related to the pathogenetic parts of Systemic lupus erythematosus. Interleukin-2 (IL-2) is a fundamental cytokine conveyed by T cells upon order and is basic for the time of T authoritative cells and incitation induced cell destruction. In SLE patients, T cells indicate reduced capacity to convey IL-2. Handicapped IL-2 expression realized lessened period of authoritative T lymphocytes, and deformation of activation affected cell passing.
· Physiological cellular reprogramming
15. Hormone Replacement Therapy:
Treating menopausal symptoms with estrogen and progestin together is known as estrogen-progestin therapy or combined hormone therapy. Hormonal replacement therapy (HRT) has a higher risk of being diagnosed with breast cancer. Before the link between HRT use and breast cancer risk was established, many postmenopausal women took HRT for many years to ease menopausal symptoms (hot flashes, fatigue) and to reduce bone loss. Since 2002, when research linked HRT and risk, the number of women taking HRT has dropped dramatically. Still, many women continue to use HRT to handle bothersome menopausal symptoms.
- postmenopausal hormone therapy
- Estrogen replacement therapy
- Menopausal hormone therapy
- Breast soreness
- Cyclic hormone therapy
16. Clinical Oncology:
Oncology is a branch of medicine that deals with the prevention, diagnosis and treatment of cancer. The three components which have improved survival in cancer are Prevention -This is by reduction of risk factors like tobacco and alcohol consumption. Treatment - Multimodality management by discussion in tumor board and treatment in a comprehensive cancer center.
- diagnosis and staging
- solid tumors
- Risk factors
17. Surgical Prevention of Cancer:
Surgery is not considered an appropriate cancer prevention option for women who are not at the highest risk of breast cancer. There have been many recent advances in cancer prevention, including improved understanding of cancer biology, better characterization of premalignant disease, significant advances in cancer surveillance, and identification of effective chemoprevention regimens. The issues governing decision making for surgical prevention vary widely among different cancer types, and include consideration of the age and level of cancer risk of the individual, the effectiveness of cancer surveillance for the particular organ at risk, the aggressiveness of the cancer once present, and the morbidity of surgery.
- lymphocele prevention
- surgical oncology
- Prolonged thrombo prophylaxis
- Urological surgery
- Esophageal cancer surgery
18. Immuno Oncology:
Immuno-oncology therapies are medicines that use the body’s immune system to fight cancer. Immuno-oncology therapiesa activate our immune system, making it able to recognise cancer cells and destroy them Immune oncology refers to immune system. It is a collection of organs, cells and special molecules that helps protect you from infections, cancer and other diseases. When a different (foreign) organism enters into the body, for example a bacterium, the immune system recognizes it and then attacks it, preventing it from causing harm. This process is called an immune response. Immuno-oncology therapies were found that provide lasting anti-cancer benefits to patients who previously had very few treatment options available to them. Several immuno-oncology therapies are in the process of being approved for use by patients in Europe, for the treatment of advanced melanoma, lung cancer, colorectal, renal, prostate cancer and many other cancers.
- Tumor microenvironment
- Tumor immunology
- Immuno-resistive drugs
- Cell and gene therapy
19. Cancer Bioinformatics:
It is another interdisciplinary region including organic, measurable and computational sciences. Now a day’s bioinformatics innovation is for the most part utilized for the special growth investigation. Ribosomal S6 protein kinase 4 (RSK4) is a vital novel tumor silencer that hinders bosom disease cell development and initiates senescence. Utilizing pair proclivity cleaning, we got protein buildings that associated with RSK4 or RSK4m. Mass range examination was performed to distinguish the acquired protein edifices, and bioinformatics investigation was performed.
- Cancer bioinformatics
- Translational bioinformatics
- Bioinformatics gene
- Bioinformatics drug
- Biology bioinformatics
20. Oncology Nursing:
An oncology nurse is a nursing professional who specializes in caring for people with cancer. Oncology nurses often serve as your first line of communication, and help coordinate the many aspects of your care throughout cancer treatment.
- Oncology nursing practice
- Primary duties
- Patient care
- Oncology nursing and cancer care
- Oncology nursing in USA
21. Advancements in Preventive Oncology:
Researchers are growing new treatments that objective specific sorts of tumor cells and limit their development. All alone or in blend with other option medications, these treatments can diminish the extent of tumors and manifestations. Some imaginative treatments give seek after individuals with malignancies that have been impervious to more medicines.
- Role of Nano technology in cancer
- Standard training on disease anticipation
- Cancer epidemiology
22. Cancer Genetics:
Cancer is a genetic disease that is, cancer is caused by certain changes to genes that control the way our cells function, especially how they grow and divide. These changes include mutations in the DNA that makes up our genes Genetic changes that increase cancer risk can be inherited from our parents if the changes are present in germ cells, which are the reproductive cells of the body (eggs and sperm). In general, cancer cells have more genetic changes than normal cells. But each person’s cancer has a unique combination of genetic alterations. Some of these changes may be the result of cancer, rather than the cause. As the cancer continues to grow, additional changes will occur. Even within the same tumor, cancer cells may have different genetic changes.
- Clinical DNA sequencing
- Genetic testing on hereditary
- Childhood cancer genomics
- Genetics of cancer